APC101 spray for postherpetic neuralgia pain relief
Part of Brain & nervous system, Infections, Pain clinical trials.
This study tests whether a spray medication called APC101 can safely reduce pain from shingles that lasts longer than 3 months. The pain usually starts after a shingles rash heals, and this trial investigates whether applying the spray to affected skin areas twice daily helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had persistent pain in one or more shingles-affected skin areas for more than 3 months (after the rash appeared)
- Your current pain level is 5 or higher on a 0–10 scale, and you can track your pain daily during a 1-week run-in period
- Your skin over the painful area is unbroken (no open wounds or sores)
- You can apply the spray yourself or have a caregiver apply it twice daily as directed
- You are willing to keep taking any pain medications you're currently on at the same dose throughout the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three injected treatments—tiny cell particles, platelet-rich plasma, and steroids—directly into the skin to reduce long-lasting nerve pain that follows shingles. If you've had persistent shingles pain for at least 3 months, this study may help ease your discomfort.
This study tests whether electroacupuncture (a gentle type of acupuncture with a mild electric current) can help relieve the pain of postherpetic neuralgia (nerve pain after shingles) and looks at how it works in the body. It compares real electroacupuncture to a sham (fake) version to see if it truly helps.
This trial tests a two-step procedure for treating nerve pain after shingles (called postherpetic neuralgia). First, a special type of radiofrequency treatment is applied to block the pain signals. Then, a long-lasting numbing medicine is injected under the skin to help keep the pain away. It is for people aged 40 to 85 who have not gotten enough relief from standard medicines.
This trial tests a new tablet called HL-1186 for treating post-herpetic neuralgia (long-lasting pain after shingles). It compares the new drug to pregabalin, a standard treatment, to see if it's safer and more effective.
This study tests a combination of a nasal spray medicine (esketamine) and a minimally invasive procedure (pulsed radiofrequency treatment of the nerve root) to treat long-lasting pain from shingles (postherpetic neuralgia). It is for adults with moderate to severe pain that has persisted for more than 3 months.
This trial tests whether a special gel containing hyaluronan (a naturally occurring substance) can reduce pain from shingles or long-term shingles nerve pain. You'd apply it to your skin to see if it helps ease discomfort.
Hear when a new PHN - Post-Herpetic Neuritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.